腹部神经母细胞瘤增强CT测量的细胞外容积分数与组织病理学特征及MYCN扩增状态的相关性:一项回顾性研究
回顾性纳入141例腹部神经母细胞瘤患者,于平扫及平衡期增强CT测量感兴趣区CT值计算细胞外容积分数(fECV)。结果显示fECV与病理亚型、MKI、Shimada分类、MYCN扩增状态、INRG分期及危险度分组相关,提示细胞外基质与肿瘤生物学行为可能存在相关性。
要点
- 腹部神经母细胞瘤fECV在神经母细胞瘤与节细胞神经母细胞瘤间存在显著差异。
- 高MKI、不良组织学及MYCN扩增的神经母细胞瘤fECV显著降低。
- fECV在不同INRG分期及危险度分组间存在显著差异。
核心结论
- 增强CT衍生的fECV与腹部神经母细胞瘤的组织病理学特征、MYCN扩增状态、INRG分期及危险度分层相关,反映细胞外基质与神经母细胞瘤生物学行为之间可能存在相关性。
研究设计与样本
- 回顾性研究,纳入141例接受增强CT扫描的腹部神经母细胞瘤患者;于平扫及平衡期增强CT上测量肿瘤及主动脉感兴趣区CT值计算fECV;采用Mann-Whitney U检验或Kruskal-Wallis检验分析fECV与病理亚型、MKI、Shimada分类、MYCN扩增状态、INRG分期及危险度分组的相关性。
诊断标准与关键数值
- 神经母细胞瘤fECV为0.349(0.252,0.424),节细胞神经母细胞瘤fECV为0.438(0.327,0.508),差异有统计学意义(Z=2.200,P=0.028)。
- 高MKI神经母细胞瘤fECV显著降低(H=8.314,P=0.016)。
- 不良组织学神经母细胞瘤fECV显著降低(Z=3.880,P<0.001)。
- MYCN扩增神经母细胞瘤fECV显著降低(Z=5.486,P<0.001)。
- 不同INRG分期之间fECV差异有统计学意义(H=16.881,P<0.001),不同危险度分组之间fECV差异有统计学意义(H=29.014,P<0.001)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To retrospectively investigate the correlations between contrast-enhanced CT (CECT)-measured extracellular volume fraction (fECV) and histopathological features, as well as MYCN amplification status, in abdominal neuroblastoma.
MATERIALS AND METHODS: One hundred and forty-one patients with abdominal neuroblastoma who underwent CECT scanning were retrospectively enrolled. Calculation of fECV involved the measurement of CT values within regions of interest located within the neuroblastoma and aorta on both non-contrast-enhanced CT and equilibrium CECT. The correlations between fECV and various factors, including pathological subtype, mitosis karyorrhexis index (MKI), Shimada classification, MYCN amplification status, International Neuroblastoma Risk Group (INRG) stage, and risk group were analyzed using either the Mann-Whitney U test or Kruskal-Wallis test.
RESULTS: Neuroblastoma and ganglioneuroblastoma exhibited fECV values of 0.349 (0.252, 0.424) and 0.438 (0.327, 0.508), respectively, indicating a statistically significant difference (Z = 2.200, P = 0.028). Additionally, the fECV decreased significantly in neuroblastoma with high MKI (H = 8.314, P = 0.016) or unfavorable histology (Z = 3.880, P < 0.001), as well as in those with MYCN amplification (Z = 5.486, P < 0.001). Notably, a significant variation in fECV was observed among different INRG stages (H = 16.881, P <0.001) and risk groups (H = 29.014, P < 0.001).
CONCLUSION: CECT-derived fECV is associated with histopathological features, MYCN amplification status, INRG stage, and risk stratification of abdominal neuroblastoma, reflecting a potential correlation between the extracellular matrix and the biological behavior of neuroblastoma.
引用
- Wang H, Ding H, Xie M, et al. Correlations between contrast-enhanced CT-measured extracellular volume fraction, histopathological features, and MYCN amplification status in abdominal neuroblastoma: a retrospective study. Abdom Radiol (NY). 2023. PMID: 37452211. doi:10.1007/s00261-023-03998-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。